J9332
HCPCSInj efgartigimod 2mg
Official HCPCS Level II long descriptor
Injection, efgartigimod alfa-fcab, 2mg
HCPCS Level II code J9332 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Inj efgartigimod 2mg
Added to HCPCS: 2022-07-01
Nearby codes in J9
- J9323Inj pemetrexed ditromethamin
- J9324Inj, pemrydi rtu, 10 mg
- J9325Inj talimogene laherparepvec
- J9326Telisotuzumab vedotin-tllv
- J9328Temozolomide injection
- J9329Inj, tislelizumab-jsgr
- J9330Temsirolimus injection
- J9331Inj sirolimus prot part 1 mg
- J9333Inj rozanolixizum-noli 1 mg
- J9334Inj efgart-alfa 2mg hya-qvfc
- J9341Inj thiotepa (tepylute) 1 mg
- J9342Inj thiotepa nos 1 mg
- J9345Inj, retifanlimab-dlwr, 1 mg
- J9347Inj, tremelimumab-actl, 1 mg
- J9348Inj. naxitamab-gqgk, 1 mg
- J9349Inj., tafasitamab-cxix
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.